Drug Development and FDA Approval, 1938–2013
Jonathan J. Darrow, Aaron Seth Kesselheim
Abstract
Jonathan J. Darrow, Aaron Seth Kesselheim
Abstract
This interactive graphic shows major legislative and regulatory events related to approval of new drugs by the Food and Drug Administration (FDA), drug approvals by year and by therapeutic category, and trends in the use of the FDA's various programs for expedited approval.
OpenAlex reports 45 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This interactive graphic shows major legislative and regulatory events related to approval of new drugs by the Food and Drug Administration (FDA), drug approvals by year and by therapeutic category, and trends in the use of the FDA's various programs for expedited approval.
Key concepts: Medicine, Food and drug administration, Drug approval, Drug, Approved drug, Drug development, Clinical research, Legislature